Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Let the time proves. November 15 is around the corner.
This hearingassist acquisitions is big. They are the hearing aid major supplier for walmart.
Plus partnerships with hyvee, hartig, etc.
With the hearingassist expected revs of 150m annually (per their pr) and all those partnerships that also bring addtl revs, this is still undervalued.
eargo revs is 60m yearly and their marketcap is 4x innd.
So if my calculation is right, comparing to eargo revs, once the acquisition goes through and revs flow,, innd should at least be 10x of this sp.
No, fern is not alex’s top play. He mentioned it once a while previously in his 20 list to play, but never been his top ones.
This is mostly moon market play. And moon always plays solid play companies.
I think people reacted to the offering amendment thas was posted today. I did not see any change to the previous offering amendment, so not sure what that was for, unless I misread it when comparing it.
The prev amendment was to update the offering price and make it higher to adjust to current price that time, between .045 and .07. And reduced the amount of offering. So it was actually a good amendment.
Next week we should start climbing again. Crypto platform Acquisition is around the corner. We are getting closer.
So far, They HAVE NOT missed any single dateline.
They also just updated their shareholders through their twitter recently, that they are still making progress at all front and on schedule with the plan. And also PR’ed about it. So that was another assurance.
Fern has well-known professional people in the management. Research their backgrounds.
That’s what I like about Fern. They present plans, give timelines, communicates, don’t pump, and delivers.
Crypto trading platform Acquisition finalized by Nov 15:
https://www.accesswire.com/661228/Fernhill-Corp-Signs-Letter-of-Intent-to-Acquire-an-Institutional-Crypto-Trading-Platform-with-Proprietary-Algorithms-Smart-Order-Routing-and-Risk-Exposure-Analytics
Bounced back pretty nice.
People know what’s coming.
Wish I can fast forward to next week.
Last week’s shakeout.
It is quite common with otc with upcoming catalyst.
2-3 weeks prior to catalyst hits is usually the momentum starts building. But 4-6 prior to it usually there is a shakeout times.
Hope this is the same pattern.
???? haha
Three more weeks or less before the acquisition announcement. Hang in there! ??
You will be fine, even if you are holding it for another week. And prob more fine if you hold it a bit longer.
Fern has big catalyst coming by November 15. Crypto is hot sector.
Everyone just chilling, holding, and adding. Waiting for this acquisition to be finalized by November 15.
We should see momentum climbing next week and weeks to come.
Crypto is hot sector.
https://www.accesswire.com/661228/Fernhill-Corp-Signs-Letter-of-Intent-to-Acquire-an-Institutional-Crypto-Trading-Platform-with-Proprietary-Algorithms-Smart-Order-Routing-and-Risk-Exposure-Analytics
Have a good weekend everyone!
They have until november 15 to close the acquisition.
Agree. Hang tight.
Thank you. I believe We all will. If we just hang tight.
It could be.
Oh I know that...
But I don’t think you understood my question... which news he is talking about?.
Fern actually has upcoming acquistion by november 15, so if we follow that logic, this should go the other way around.
Not sure what you mean with the news. The big catalyst (acquisition) is not even hit yet. They are buying crypto tradinv platform and will be finalized by november 15.
https://www.otcmarkets.com/stock/FERN/news/Fernhill-Corp-Signs-Letter-of-Intent-to-Acquire-an-Institutional-Crypto-Trading-Platform-with-Proprietary-Algorithms-Sma?id=317938
EUA... once EUA submitted, we will get to 0.1 point, and everything missing pieces in puzzle will start filling in.
The insider has to file form 4 if they are selling. Be careful spreading false information or accusation, you can be libel.
Not much changed on the overall Outstanding Shares, but they seem to move some shares from Restricted to Unrestricted.
Quite common for biotech that has on-going drug research/ development.
Agree with you and doog.
Tsoi has great potential, but definitely not for daytrading.
Patience will be greatly rewarded here.
Nope. Incorrect.
The EUA and phase 3 will be two separate process.
EUA submission does not need to wait for Ph 3 process/timelines. Tim had mentioned this as well.
Yes!
I am rooting for EUA. The sooner the better. Lots of people need access to this treatment more than anyone can imagine. It will increase the ventilator patients survival rates significantly and many more lives can be saved.
Phase 3 has not started yet.
Tim had mentioned that.
The phase 3 and eua submission will be submitted (done) in parallel. There will be 2 separate process.
Nice..
Go and visit him.
I bet he’ll be thrilled to see you. :)
I believe it was mentioned in the forum before that Tsoi actually keep both california and the idaho offices.
Logically, If the Ph 3 is completed and result is as good as phase 1 and 2, tsoi just need to submit for FDA fully approval, why bother for EUA?
So yes, EUA can be submitted anytime now.
Its submittal alone will pop the sp back up again, the approval will make it fly. As the revs will be coming soon with it.
So, if we believe in their products, just be patience, we will be rewarded.
Are we talking about the same product here?
Human trials have been done in prev phases with 100% survival rates on group of age <85 yo, and 91% survival rates on group of age >85 yo.
The EUA submission does not require to wait for any more trials completed as they have enough data to present. They just need to fulfill all the 4 checklist.
However, tsoi will still have to move forward with phase 3 trials in order to get a full fda approval for a wide market sell.
Satisfying The EUA Criteria
The FDA has established four broad criteria that must be met in order to participate in the EUA program and be granted an EUA:
1. Presence of a serious or life-threatening condition
2. Evidence of effectiveness
3. Risk-benefit analysis (safety)
4. No other alternatives to address the life-threatening condition
Tim had mentioned in the forum.
My understanding from reading his explanations.
Submitting EUA and Phase 3 trials will be two separate process.
The EUA needs very little operational cost. Once it is approved, hospital can buy the product and pay in advanced, which means revs for the company. The EUA could be submitted anytime now.
The Phase 3 trials will be conducted after the Funding is secured. If the EUA is approved, that means it can fund the Ph 3 itself.
So based on his explanations alone, I don’t know how one can conclude EUA will be submitted after phase 3 is conducted. Not making any sense.